{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:55:55Z","timestamp":1785815755736,"version":"3.56.0"},"reference-count":97,"publisher":"The Fukushima Society of Medical Science","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FJMS","Fukushima J. Med. Sci."],"published-print":{"date-parts":[[2024]]},"DOI":"10.5387\/fms.23-00019","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T22:10:01Z","timestamp":1719353401000},"page":"119-131","source":"Crossref","is-referenced-by-count":5,"title":["Current status of research on sarcopenia in post-treatment cancer survivors in Japan:A narrative review"],"prefix":"10.5387","volume":"70","author":[{"given":"Keiichi","family":"Osaki","sequence":"first","affiliation":[{"name":"Department of Rehabilitation, Panasonic Health Insurance Organization, Matsushita Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Faculty of Rehabilitation, Kansai Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Rehabilitation Medicine, Shizuoka Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiho","family":"Kamimura","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Panasonic Health Insurance Organization, Matsushita Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Yanai","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Panasonic Health Insurance Organization, Matsushita Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Morishita","sequence":"additional","affiliation":[{"name":"Department of Physical Therapy, School of Health Science, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3342","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, <i>et al.<\/i> Sarcopenia:European consensus on definition and diagnosis:Report of the European Working Group on Sarcopenia in Older People. Age Ageing, <b>39<\/b>:412-423, 2010.","DOI":"10.1093\/ageing\/afq034"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Anjanappa M, Corden M, Green A, <i>et al.<\/i> Sarcopenia in cancer:Risking more than muscle loss. Tech Innov Patient Support Radiat Oncol, <b>16<\/b>:50-57, 2020.","DOI":"10.1016\/j.tipsro.2020.10.001"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chen LK, Woo J, Assantachai P, <i>et al.<\/i> Asian Working Group for Sarcopenia:2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc, <b>21<\/b>:300-307.e2, 2020.","DOI":"10.1016\/j.jamda.2019.12.012"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Williams GR, Rier HN, McDonald A, Shachar SS. Sarcopenia &amp; aging in cancer. J Geriatr Oncol, <b>10<\/b>:374-377, 2019.","DOI":"10.1016\/j.jgo.2018.10.009"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Zhang XM, Dou QL, Zeng Y, Yang Y, Cheng ASK, Zhang WW. Sarcopenia as a predictor of mortality in women with breast cancer:a meta-analysis and systematic review. BMC Cancer, <b>20<\/b>:172, 2020.","DOI":"10.1186\/s12885-020-6645-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Morlino D, Marra M, Cioffi I, <i>et al.<\/i> Prevalence of Sarcopenia in Women with Breast Cancer. Nutrients, <b>14<\/b>:1839, 2022.","DOI":"10.3390\/nu14091839"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Surov A, Wienke A. Prevalence of sarcopenia in patients with solid tumors:A meta-analysis based on 81,814 patients. JPEN J Parenter Enteral Nutr, <b>46<\/b>:1761-1768, 2022.","DOI":"10.1002\/jpen.2415"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Davis MP, Panikkar R. Sarcopenia associated with chemotherapy and targeted agents for cancer therapy. Ann Palliat Med, <b>8<\/b>:86-101, 2019.","DOI":"10.21037\/apm.2018.08.02"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Anjanappa M, Corden M, Green A, <i>et al.<\/i> Sarcopenia in cancer:Risking more than muscle loss. Tech Innov Patient Support Radiat Oncol, <b>16<\/b>:50-57, 2020.","DOI":"10.1016\/j.tipsro.2020.10.001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sousa IM, Fayh APT. Is the ECOG-PS similar to the sarcopenia status for predicting mortality in older adults with cancer? A prospective cohort study. Support Care Cancer, <b>31<\/b>:370, 2023.","DOI":"10.1007\/s00520-023-07845-w"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. van Rijn-Dekker MI, van den Bosch L, van den Hoek JGM, <i>et al.<\/i> Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy. Radiother Oncol, <b>147<\/b>:103-110, 2020.","DOI":"10.1016\/j.radonc.2020.03.014"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nipp RD, Fuchs G, El-Jawahri A, <i>et al.<\/i> Sarcopenia Is Associated with Quality of Life and Depression in Patients with Advanced Cancer. Oncologist, <b>23<\/b>:97-104, 2018.","DOI":"10.1634\/theoncologist.2017-0255"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Besson A, Deftereos I, Gough K, Taylor D, Shannon R, Yeung JM. Correction to:The association between sarcopenia and quality of life in patients undergoing colorectal cancer surgery:an exploratory study. Support Care Cancer, <b>29<\/b>:3421, 2021.","DOI":"10.1007\/s00520-021-06096-x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bye A, Sj\u00f8blom B, Wentzel-Larsen T, <i>et al.<\/i> Muscle mass and association to quality of life in non-small cell lung cancer patients. J Cachexia Sarcopenia Muscle, <b>8<\/b>:759-767, 2017.","DOI":"10.1002\/jcsm.12206"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Barreto CS, Borges TC, Valentino NP, <i>et al.<\/i> Absence of risk of sarcopenia protects cancer patients from fatigue. Eur J Clin Nutr, <b>76<\/b>:206-211, 2022.","DOI":"10.1038\/s41430-021-00931-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wang B, Thapa S, Zhou T, <i>et al.<\/i> Cancer-related fatigue and biochemical parameters among cancer patients with different stages of sarcopenia. Support Care Cancer, <b>28<\/b>:581-588, 2020.","DOI":"10.1007\/s00520-019-04717-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ito Y, Miyashiro I, Ito H, <i>et al.<\/i> Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry data. Cancer Sci, <b>105<\/b>:1480-1486, 2014.","DOI":"10.1111\/cas.12525"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Arends J, Bachmann P, Baracos V, <i>et al.<\/i> ESPEN guidelines on nutrition in cancer patients. Clin Nutr, <b>36<\/b>:11-48, 2017.","DOI":"10.1016\/j.clnu.2016.07.015"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Clemente-Su\u00e1rez VJ, Redondo-Fl\u00f3rez L, Rubio-Zarapuz A, Mart\u00ednez-Guardado I, Navarro-Jim\u00e9nez E, Tornero-Aguilera JF. Nutritional and Exercise Interventions in Cancer-Related Cachexia:An Extensive Narrative Review. Int J Environ Res Public Health, <b>19<\/b>:4604, 2022.","DOI":"10.3390\/ijerph19084604"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Cortiula F, Hendriks LEL, van de Worp WRPH, <i>et al.<\/i> Physical exercise at the crossroad between muscle wasting and the immune system:implications for lung cancer cachexia. J Cachexia Sarcopenia Muscle, <b>13<\/b>:55-67, 2022.","DOI":"10.1002\/jcsm.12900"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kurz E, Hirsch CA, Dalton T, <i>et al.<\/i> Exercise-induced engagement of the IL-15\/IL-15R\u03b1 axis promotes anti-tumor immunity in pancreatic cancer. Cancer Cell, <b>40<\/b>:720-737.e5, 2022.","DOI":"10.1016\/j.ccell.2022.05.006"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Koivula T, Lempi\u00e4inen S, Rinne P, <i>et al.<\/i> The effect of acute exercise on circulating immune cells in newly diagnosed breast cancer patients. Sci Rep, <b>13<\/b>:6561, 2023.","DOI":"10.1038\/s41598-023-33432-4"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Park YJ, Lee YM. Association among the Prevalence of Sarcopenia without Obesity, Nonsarcopenic Obesity, Sarcopenic Obesity, and Metabolic Syndrome in Cancer Survivors:Based on Korea National Health and Nutrition Examination Survey. Asia Pac J Oncol Nurs, <b>8<\/b>:679-686, 2021.","DOI":"10.4103\/apjon.apjon-2116"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lee SJ, Kim NC. Association Between Sarcopenia and Metabolic Syndrome in Cancer Survivors. Cancer Nurs, <b>40<\/b>:479-487, 2017.","DOI":"10.1097\/NCC.0000000000000454"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Aduse-Poku L, Karanth SD, Wheeler M, <i>et al.<\/i> Associations of Total Body Fat Mass and Skeletal Muscle Index with All-Cause and Cancer-Specific Mortality in Cancer Survivors. Cancers (Basel), <b>15<\/b>:1081, 2023.","DOI":"10.3390\/cancers15041081"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kim EY, Kim K, Kim YS, <i>et al.<\/i> Prevalence of and Factors Associated with Sarcopenia in Korean Cancer Survivors:Based on Data Obtained by the Korea National Health and Nutrition Examination Survey (KNHANES) 2008-2011. Nutr Cancer, <b>69<\/b>:394-401, 2017.","DOI":"10.1080\/01635581.2017.1267776"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Lee SJ, Park YJ, Cartmell KB. Sarcopenia in cancer survivors is associated with increased cardiovascular disease risk. Support Care Cancer, <b>26<\/b>:2313-2321, 2018.","DOI":"10.1007\/s00520-018-4083-7"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Villase\u00f1or A, Ballard-Barbash R, Baumgartner K, <i>et al.<\/i> Prevalence and prognostic effect of sarcopenia in breast cancer survivors:the HEAL Study. J Cancer Surviv, <b>6<\/b>:398-406, 2012.","DOI":"10.1007\/s11764-012-0234-x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Benavides-Rodr\u00edguez L, Garc\u00eda-Hermoso A, Rodrigues-Bezerra D, Izquierdo M, Correa-Bautista JE, Ram\u00edrez-V\u00e9lez R. Relationship between Handgrip Strength and Muscle Mass in Female Survivors of Breast Cancer:A Mediation Analysis. Nutrients, <b>9<\/b>:695, 2017.","DOI":"10.3390\/nu9070695"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. van Atteveld JE, de Winter DTC, Pluimakers VG, <i>et al.<\/i> Frailty and sarcopenia within the earliest national Dutch childhood cancer survivor cohort (DCCSS-LATER):a cross-sectional study. Lancet Healthy Longev, <b>4<\/b>:e155-e165, 2023.","DOI":"10.1016\/S2666-7568(23)00020-X"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. McCastlain K, Howell CR, Welsh CE, <i>et al.<\/i> The Association of Mitochondrial Copy Number With Sarcopenia in Adult Survivors of Childhood Cancer. J Natl Cancer Inst, <b>113<\/b>:1570-1580, 2021.","DOI":"10.1093\/jnci\/djab084"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Takahashi S, Shimizu S, Nagai S, Watanabe H, Nishitani Y, Kurisu Y. Characteristics of sarcopenia after distal gastrectomy in elderly patients. PLoS One, <b>14<\/b>:e0222412, 2019.","DOI":"10.1371\/journal.pone.0222412"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Hijikata N, Ishikawa A, Matsuda S, <i>et al.<\/i> Effect of Postoperative Oral Intake Status on Sarcopenia Six Months After Esophageal Cancer Surgery [published correction appears in Dysphagia. 2022 Dec 21;:]. Dysphagia, <b>38<\/b>:340-350, 2023.","DOI":"10.1007\/s00455-022-10471-z"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Nakayama H, Noguchi M, Fukano R, <i>et al.<\/i> Sarcopenia and obesity in long-term survivors of childhood leukemia\/lymphoma:a report from a single institution. Jpn J Clin Oncol, <b>51<\/b>:1100-1106, 2021.","DOI":"10.1093\/jjco\/hyab046"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and Cancer:A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management. Cancers (Basel), <b>15<\/b>:485, 2023.","DOI":"10.3390\/cancers15020485"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Mostoufi-Moab S, Ginsberg JP, Bunin N, <i>et al.<\/i> Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation. J Pediatr, <b>160<\/b>:122-128, 2012.","DOI":"10.1016\/j.jpeds.2011.06.041"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Kohara K. Sarcopenic obesity in aging population:current status and future directions for research. Endocrine, <b>45<\/b>:15-25, 2014.","DOI":"10.1007\/s12020-013-9992-0"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Kohara K, Ochi M, Tabara Y, Nagai T, Igase M, Miki T. Arterial stiffness in sarcopenic visceral obesity in the elderly:J-SHIPP study. Int J Cardiol, <b>158<\/b>:146-148, 2012.","DOI":"10.1016\/j.ijcard.2012.04.033"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Prado CM, Lieffers JR, McCargar LJ, <i>et al.<\/i> Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts:a population-based study. Lancet Oncol, <b>9<\/b>:629-635, 2008.","DOI":"10.1016\/S1470-2045(08)70153-0"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Veronese N, Facchini S, Stubbs B, <i>et al.<\/i> Weight loss is associated with improvements in cognitive function among overweight and obese people:A systematic review and meta-analysis. Neurosci Biobehav Rev, <b>72<\/b>:87-94, 2017.","DOI":"10.1016\/j.neubiorev.2016.11.017"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Tschann P, Weigl MP, Clemens P, <i>et al.<\/i> Sarcopenic Obesity Is a Risk Factor for Worse Oncological Long-Term Outcome in Locally Advanced Rectal Cancer Patients:A Retrospective Single-Center Cohort Study. Nutrients, <b>15<\/b>:2632, 2023.","DOI":"10.3390\/nu15112632"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Malhotra P, Kapoor G, Jain S, Jain S, Sharma A. Obesity and Sarcopenia in Survivors of Childhood Acute Lymphoblastic Leukemia. Indian Pediatr, <b>58<\/b>:436-440, 2021.","DOI":"10.1007\/s13312-021-2213-7"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Marriott CJC, Beaumont LF, Farncombe TH, <i>et al.<\/i> Body composition in long-term survivors of acute lymphoblastic leukemia diagnosed in childhood and adolescence:A focus on sarcopenic obesity. Cancer, <b>124<\/b>:1225-1231, 2018.","DOI":"10.1002\/cncr.31191"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, Sawyer DB. Anthracycline cardiotoxicity:from bench to bedside. J Clin Oncol, <b>26<\/b>:3777-3784, 2008.","DOI":"10.1200\/JCO.2007.14.9401"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Ewer SM, Ewer MS. Cardiotoxicity profile of trastuzumab. Drug Saf, <b>31<\/b>:459-467, 2008.","DOI":"10.2165\/00002018-200831060-00002"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Choueiri TK, Mayer EL, Je Y, <i>et al.<\/i> Congestive heart failure risk in patients with breast cancer treated with bevacizumab. J Clin Oncol, <b>29<\/b>:632-638, 2011.","DOI":"10.1200\/JCO.2010.31.9129"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Okwuosa TM, Anzevino S, Rao R. Cardiovascular disease in cancer survivors. Postgrad Med J, <b>93<\/b>:82-90, 2017.","DOI":"10.1136\/postgradmedj-2016-134417"},{"key":"48","unstructured":"48. Florido R, Daya NR, Ndumele CE, <i>et al.<\/i> Cardiovascular Disease Risk Among Cancer Survivors:The Atherosclerosis Risk In Communities (ARIC) Study. J Am Coll Cardiol, <b>80<\/b>:22-32, 2022."},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Rugbjerg K, Mellemkjaer L, Boice JD, K\u00f8ber L, Ewertz M, Olsen JH. Cardiovascular disease in survivors of adolescent and young adult cancer:a Danish cohort study, 1943-2009. J Natl Cancer Inst, <b>106<\/b>:dju110, 2014.","DOI":"10.1093\/jnci\/dju110"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Fitzgerald MD, Tanaka H, Tran ZV, Seals DR. Age-related declines in maximal aerobic capacity in regularly exercising vs. sedentary women:a meta-analysis. J Appl Physiol (1985), <b>83<\/b>:160-165, 1997.","DOI":"10.1152\/jappl.1997.83.1.160"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Lee K. Sarcopenic obesity and 10-year cardiovascular disease risk scores in cancer survivors and non-cancer participants using a nationwide survey. Eur J Cancer Care (Engl), <b>32<\/b>:e13365, 2021","DOI":"10.1111\/ecc.13365"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Koene RJ, Prizment AE, Blaes A, Konety SH. Shared Risk Factors in Cardiovascular Disease and Cancer. Circulation, <b>133<\/b>:1104-1114, 2016","DOI":"10.1161\/CIRCULATIONAHA.115.020406"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Argil\u00e9s JM, Busquets S, Stemmler B, L\u00f3pez-Soriano FJ. Cancer cachexia:understanding the molecular basis. Nat Rev Cancer, <b>14<\/b>:754-762, 2014.","DOI":"10.1038\/nrc3829"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Arai H, Maeda K, Wakabayashi H, <i>et al.<\/i> Diagnosis and outcomes of cachexia in Asia:Working Consensus Report from the Asian Working Group for Cachexia. J Cachexia Sarcopenia Muscle, <b>14<\/b>:1949-1958, 2023.","DOI":"10.1002\/jcsm.13323"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Antoun S, Morel H, Souquet PJ, <i>et al.<\/i> Staging of nutrition disorders in non-small-cell lung cancer patients:utility of skeletal muscle mass assessment. J Cachexia Sarcopenia Muscle, <b>10<\/b>:782-793, 2019.","DOI":"10.1002\/jcsm.12418"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Dunne RF, Roussel B, Culakova E, <i>et al.<\/i> Characterizing cancer cachexia in the geriatric oncology population. J Geriatr Oncol, <b>10<\/b>:415-419, 2019.","DOI":"10.1016\/j.jgo.2018.08.008"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Takayama K, Atagi S, Imamura F, <i>et al.<\/i> Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study. Support Care Cancer, <b>24<\/b>:3473-3480, 2016.","DOI":"10.1007\/s00520-016-3156-8"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Naito T, Okayama T, Aoyama T, <i>et al.<\/i> Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancer. BMC Cancer, <b>17<\/b>:571, 2017.","DOI":"10.1186\/s12885-017-3562-4"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Rock CL, Thomson CA, Sullivan KR, <i>et al.<\/i> American Cancer Society nutrition and physical activity guideline for cancer survivors. CA Cancer J Clin, <b>72<\/b>:230-262, 2022.","DOI":"10.3322\/caac.21721"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Campbell KL, Winters-Stone KM, Wiskemann J, <i>et al.<\/i> Exercise Guidelines for Cancer Survivors:Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc, <b>51<\/b>:2375-2390, 2019.","DOI":"10.1249\/MSS.0000000000002116"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Morishita S, Suzuki K, Okayama T, <i>et al.<\/i> Recent Findings in Physical Exercise for Cancer Survivors. Phys Ther Res, <b>26<\/b>:10-16, 2023.","DOI":"10.1298\/ptr.R0023"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Ng AH, Ngo-Huang A, Vidal M, <i>et al.<\/i> Exercise Barriers and Adherence to Recommendations in Patients With Cancer. JCO Oncol Pract, <b>17<\/b>:e972-e981, 2021.","DOI":"10.1200\/OP.20.00625"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Coletta AM, Marquez G, Thomas P, <i>et al.<\/i> Clinical factors associated with adherence to aerobic and resistance physical activity guidelines among cancer prevention patients and survivors. PLoS One, <b>14<\/b>:e0220814, 2019.","DOI":"10.1371\/journal.pone.0220814"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Upshaw JN, Hubbard RA, Hu J, <i>et al.<\/i> Physical activity during and after breast cancer therapy and associations of baseline physical activity with changes in cardiac function by echocardiography. Cancer Med, <b>9<\/b>:6122-6131, 2020.","DOI":"10.1002\/cam4.3277"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Kasahara R, Fujita T, Jinbo R, <i>et al.<\/i> Impact of Sarcopenia on Outcome of Exercise Therapy in Older Non-Hodgkin Lymphoma Patients. Integr Cancer Ther, <b>22<\/b>:15347354231210775, 2023.","DOI":"10.1177\/15347354231210775"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Cao A, Ferrucci LM, Caan BJ, Irwin ML. Effect of Exercise on Sarcopenia among Cancer Survivors:A Systematic Review. Cancers (Basel), <b>14<\/b>:786, 2022.","DOI":"10.3390\/cancers14030786"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, <i>et al.<\/i> Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer:A Randomized Controlled Trial [published correction appears in J Clin Oncol. 2020 Apr 20;<b>38<\/b>(12):1370] [published correction appears in J Clin Oncol. 2020 Jun 20;<b>38<\/b>(18):2115]. J Clin Oncol, <b>36<\/b>:875-883, 2018.","DOI":"10.1200\/JCO.2017.75.7526"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Katakami N, Uchino J, Yokoyama T, <i>et al.<\/i> Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia:Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04). Cancer, <b>124<\/b>:606-616, 2018.","DOI":"10.1002\/cncr.31128"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Hamauchi S, Furuse J, Takano T, <i>et al.<\/i> A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia. Cancer, <b>125<\/b>:4294-4302, 2019.","DOI":"10.1002\/cncr.32406"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Mouri T, Naito T, Morikawa A, <i>et al.<\/i> Promotion of Behavioral Change and the Impact on Quality of Life in Elderly Patients with Advanced Cancer:A Physical Activity Intervention of the Multimodal Nutrition and Exercise Treatment for Advanced Cancer Program. Asia Pac J Oncol Nurs, <b>5<\/b>:383-390, 2018.","DOI":"10.4103\/apjon.apjon_21_18"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Naito T, Mitsunaga S, Miura S, <i>et al.<\/i> Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer. J Cachexia Sarcopenia Muscle, <b>10<\/b>:73-83, 2019.","DOI":"10.1002\/jcsm.12351"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Yennurajalingam S, Basen-Engquist K, Reuben JM, <i>et al.<\/i> Anamorelin combined with physical activity, and nutritional counseling for cancer-related fatigue:a preliminary study. Support Care Cancer, <b>30<\/b>:497-509, 2022.","DOI":"10.1007\/s00520-021-06463-8"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Takayama K, Takiguchi T, Komura N, Naito T. Efficacy and safety of anamorelin in patients with cancer cachexia:Post-hoc subgroup analyses of a placebo-controlled study. Cancer Med, <b>12<\/b>:2918-2928, 2023.","DOI":"10.1002\/cam4.5206"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Liu X, Xu X, Cheung DST, <i>et al.<\/i> The effects of exercise with or without dietary advice on muscle mass, muscle strength, and physical functioning among older cancer survivors:a meta-analysis of randomized controlled trials [published online ahead of print, 2023 Jun 2]. J Cancer Surviv, 1-9, 2023.","DOI":"10.1007\/s11764-023-01396-z"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Grande AJ, Silva V, Riera R, <i>et al.<\/i> Exercise for cancer cachexia in adults. Cochrane Database Syst Rev, (11):CD010804, 2014.","DOI":"10.1002\/14651858.CD010804.pub2"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Grande AJ, Silva V, Sawaris Neto L, Teixeira Basmage JP, Peccin MS, Maddocks M. Exercise for cancer cachexia in adults. Cochrane Database Syst Rev, <b>3<\/b>:CD010804, 2021.","DOI":"10.1002\/14651858.CD010804.pub3"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Edvardsen E, Skj\u00f8nsberg OH, Holme I, Nordsletten L, Borchsenius F, Anderssen SA. High-intensity training following lung cancer surgery:a randomised controlled trial. Thorax, <b>70<\/b>:244-250, 2015.","DOI":"10.1136\/thoraxjnl-2014-205944"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Tsuji K, Ochi E, Okubo R, <i>et al.<\/i> Effect of home-based high-intensity interval training and behavioural modification using information and communication technology on cardiorespiratory fitness and exercise habits among sedentary breast cancer survivors:habit-B study protocol for a randomised controlled trial. BMJ Open, <b>9<\/b>:e030911, 2019.","DOI":"10.1136\/bmjopen-2019-030911"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Ochi E, Tsuji K, Narisawa T, <i>et al.<\/i> Cardiorespiratory fitness in breast cancer survivors:a randomised controlled trial of home-based smartphone supported high intensity interval training. BMJ Support Palliat Care, <b>12<\/b>:33-37, 2022.","DOI":"10.1136\/bmjspcare-2021-003141"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Onyeaka HK, Zambrano J, Longley RM, Celano CM, Naslund JA, Amonoo HL. Use of digital health tools for health promotion in cancer survivors. Psychooncology, <b>30<\/b>:1302-1310, 2021.","DOI":"10.1002\/pon.5677"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Martin-Martin L, <i>et al.<\/i> A Mobile System to Improve Quality of Life Via Energy Balance in Breast Cancer Survivors (BENECA mHealth):Prospective Test-Retest Quasiexperimental Feasibility Study. JMIR Mhealth Uhealth, <b>7<\/b>:e14136, 2019.","DOI":"10.2196\/14136"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Lozano-Lozano M, Galiano-Castillo N, Gonzalez-Santos A, <i>et al.<\/i> Effect of mHealth plus occupational therapy on cognitive function, mood and physical function in people after cancer:Secondary analysis of a randomized controlled trial. Ann Phys Rehabil Med, <b>66<\/b>:101681, 2023.","DOI":"10.1016\/j.rehab.2022.101681"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Lozano-Lozano M, Mart\u00edn-Mart\u00edn L, Galiano-Castillo N, <i>et al.<\/i> Mobile health and supervised rehabilitation versus mobile health alone in breast cancer survivors:Randomized controlled trial. Ann Phys Rehabil Med, <b>63<\/b>:316-324, 2020.","DOI":"10.1016\/j.rehab.2019.07.007"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, <i>et al.<\/i> Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors:a randomized controlled trial. Breast Cancer Res, <b>20<\/b>:124, 2018.","DOI":"10.1186\/s13058-018-1051-6"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Rogers LQ, Courneya KS, Anton PM, <i>et al.<\/i> Effects of the BEAT Cancer physical activity behavior change intervention on physical activity, aerobic fitness, and quality of life in breast cancer survivors:a multicenter randomized controlled trial. Breast Cancer Res Treat, <b>149<\/b>:109-119, 2015.","DOI":"10.1007\/s10549-014-3216-z"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Toohey K, Pumpa K, McKune A, <i>et al.<\/i> The impact of high-intensity interval training exercise on breast cancer survivors:a pilot study to explore fitness, cardiac regulation and biomarkers of the stress systems. BMC Cancer, <b>20<\/b>:787, 2020","DOI":"10.1186\/s12885-020-07295-1"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Pinto BM, Papandonatos GD, Goldstein MG, Marcus BH, Farrell N. Home-based physical activity intervention for colorectal cancer survivors. Psychooncology, <b>22<\/b>:54-64, 2013.","DOI":"10.1002\/pon.2047"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Adams SC, DeLorey DS, Davenport MH, <i>et al.<\/i> Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors:A phase 2 randomized controlled trial. Cancer, <b>123<\/b>:4057-4065, 2017.","DOI":"10.1002\/cncr.30859"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. Sase K, Kida K, Furukawa Y. Cardio-Oncology rehabilitation- challenges and opportunities to improve cardiovascular outcomes in cancer patients and survivors. J Cardiol, <b>76<\/b>:559-567, 2020.","DOI":"10.1016\/j.jjcc.2020.07.014"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90. Kawaguchi Y, Hanaoka J, Ohshio Y, <i>et al.<\/i> Sarcopenia increases the risk of post-operative recurrence in patients with non-small cell lung cancer. PLoS One, <b>16<\/b>:e0257594, 2021.","DOI":"10.1371\/journal.pone.0257594"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91. Nelke C, Dziewas R, Minnerup J, Meuth SG, Ruck T. Skeletal muscle as potential central link between sarcopenia and immune senescence. EBioMedicine, <b>49<\/b>:381-388, 2019.","DOI":"10.1016\/j.ebiom.2019.10.034"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Battaglini CL, Hackney AC, Garcia R, Groff D, Evans E, Shea T. The effects of an exercise program in leukemia patients. Integr Cancer Ther, <b>8<\/b>:130-138, 2009.","DOI":"10.1177\/1534735409334266"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. Rogers LQ, Fogleman A, Trammell R, <i>et al.<\/i> Effects of a physical activity behavior change intervention on inflammation and related health outcomes in breast cancer survivors:pilot randomized trial. Integr Cancer Ther, <b>12<\/b>:323-335, 2013.","DOI":"10.1177\/1534735412449687"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94. Bower JE, Greendale G, Crosswell AD, <i>et al.<\/i> Yoga reduces inflammatory signaling in fatigued breast cancer survivors:a randomized controlled trial. Psychoneuroendocrinology, <b>43<\/b>:20-29, 2014.","DOI":"10.1016\/j.psyneuen.2014.01.019"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95. Shimizu Y, Tsuji K, Ochi E, <i>et al.<\/i> Oncology care providers\u2019 awareness and practice related to physical activity promotion for breast cancer survivors and barriers and facilitators to such promotion:a nationwide cross-sectional web-based survey. Support Care Cancer, <b>30<\/b>:3105-3118, 2022.","DOI":"10.1007\/s00520-021-06706-8"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96. Okubo R, Wada S, Shimizu Y, <i>et al.<\/i> Expectations of and recommendations for a cancer survivorship guideline in Japan:a literature review of guidelines for cancer survivorship. Jpn J Clin Oncol, <b>49<\/b>:812-822, 2019.","DOI":"10.1093\/jjco\/hyz070"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97. Fukushima T, Tsuji T, Watanabe N, <i>et al.<\/i> Cancer Rehabilitation Provided by Designated Cancer Hospitals in Japan:The Current State of Outpatient Setting and Coordination after Discharge. Prog Rehabil Med, <b>7<\/b>:20220006, 2022.","DOI":"10.2490\/prm.20220006"}],"container-title":["FUKUSHIMA JOURNAL OF MEDICAL SCIENCE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/70\/3\/70_23-00019\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T04:35:14Z","timestamp":1722054914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/70\/3\/70_23-00019\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5387\/fms.23-00019","relation":{},"ISSN":["0016-2590","2185-4610"],"issn-type":[{"value":"0016-2590","type":"print"},{"value":"2185-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"23-00019"}}